BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 990 filers reported holding BAXTER INTL INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $306,071 | +120400.4% | 8,110 | +45.3% | 0.01% | +7.7% |
| Q2 2023 | $254 | -2.3% | 5,580 | -12.9% | 0.01% | 0.0% |
| Q1 2023 | $260 | -55.3% | 6,410 | -43.8% | 0.01% | -53.6% |
| Q4 2022 | $582 | -100.0% | 11,410 | -50.3% | 0.03% | -61.1% |
| Q3 2022 | $1,236,000 | -18.8% | 22,950 | -3.2% | 0.07% | -18.2% |
| Q2 2022 | $1,523,000 | -14.6% | 23,710 | +3.1% | 0.09% | -9.3% |
| Q1 2022 | $1,783,000 | -12.1% | 23,000 | -2.7% | 0.10% | -23.0% |
| Q4 2021 | $2,029,000 | +8.4% | 23,640 | +1.6% | 0.13% | -5.3% |
| Q3 2021 | $1,872,000 | -1.3% | 23,277 | -1.2% | 0.13% | +47.8% |
| Q2 2021 | $1,896,000 | -2.9% | 23,551 | +1.8% | 0.09% | -37.5% |
| Q1 2021 | $1,952,000 | -9.9% | 23,141 | -14.3% | 0.14% | -32.7% |
| Q4 2020 | $2,167,000 | +1.3% | 27,010 | +1.5% | 0.21% | -8.9% |
| Q3 2020 | $2,139,000 | -27.3% | 26,600 | -22.1% | 0.24% | -15.8% |
| Q2 2020 | $2,942,000 | +152.5% | 34,165 | +138.2% | 0.28% | +26.8% |
| Q1 2020 | $1,165,000 | -62.4% | 14,343 | -61.3% | 0.22% | -15.4% |
| Q4 2019 | $3,098,000 | -24.4% | 37,053 | -20.9% | 0.26% | -21.7% |
| Q3 2019 | $4,096,000 | +9.3% | 46,833 | +2.4% | 0.33% | +5.7% |
| Q2 2019 | $3,747,000 | +2.2% | 45,745 | +1.4% | 0.31% | +1.3% |
| Q1 2019 | $3,668,000 | +22.5% | 45,115 | -0.8% | 0.31% | +11.1% |
| Q4 2018 | $2,994,000 | -9.8% | 45,495 | +5.7% | 0.28% | +3.3% |
| Q3 2018 | $3,319,000 | +23.2% | 43,055 | +18.0% | 0.27% | +13.0% |
| Q2 2018 | $2,694,000 | +20.4% | 36,490 | +6.1% | 0.24% | +12.2% |
| Q1 2018 | $2,237,000 | -1.1% | 34,390 | -1.8% | 0.21% | -0.9% |
| Q4 2017 | $2,263,000 | +3.9% | 35,010 | +0.9% | 0.22% | +0.5% |
| Q3 2017 | $2,178,000 | +1.0% | 34,710 | -2.5% | 0.21% | -3.2% |
| Q2 2017 | $2,156,000 | +35.3% | 35,610 | +16.0% | 0.22% | +30.0% |
| Q1 2017 | $1,593,000 | +19.2% | 30,710 | +2.0% | 0.17% | +14.1% |
| Q4 2016 | $1,336,000 | -5.5% | 30,120 | +1.4% | 0.15% | -10.2% |
| Q3 2016 | $1,414,000 | +57.1% | 29,700 | +49.2% | 0.17% | +28.7% |
| Q2 2016 | $900,000 | +114.8% | 19,900 | +240.8% | 0.13% | +30.3% |
| Q3 2014 | $419,000 | -2.3% | 5,840 | -1.7% | 0.10% | +12.5% |
| Q2 2014 | $429,000 | -14.7% | 5,940 | -13.2% | 0.09% | -19.3% |
| Q1 2014 | $503,000 | +78.4% | 6,840 | +59.5% | 0.11% | +70.3% |
| Q3 2013 | $282,000 | -28.1% | 4,288 | -24.0% | 0.06% | -30.4% |
| Q2 2013 | $392,000 | – | 5,645 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |